Published

Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2025-09-01
Source: PubMed
DOI: 10.1177/02698811251338232
PubMed: 40437853

Authors

Vella Y Syrová K Petrušková A Koutrouli I Kútna V Pala J Šíchová K Nikolič M Mazoch V Jurok R Kuchař M Bendová Z Páleníček T

Watch author

Derived topics and classifications

psilocin Neuroplasticity Mechanism of Action Biomarkers Animal Study In Vitro Study Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.2025-09-01

Related papers

Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy ParticipantsClinicalTrials.gov · 2026-04-02 Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and NeuroprotectionZenodo (CERN European Organization for Nuclear Research) · 2026-03-01 Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19 Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)ClinicalTrials.gov · 2025-03-27 The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been IdentifiedJournal of Forensic Sciences · 2020-09-01 Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced MeditatorsClinicalTrials.gov · 2023-09-21